30 results
8-K
EX-99.1
VRNA
Verona Pharma plc
9 May 24
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
7:18am
investment in Verona Pharma underscores Oaktree’s commitment to provide flexible capital solutions to innovative life sciences companies
PRE 14A
64h v8e185hf5ihmcr
8 Mar 24
Preliminary proxy
4:18pm
8-K
EX-10.1
g90epxma7qak
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
EX-99.1
d0cjeot4e4eb
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
EX-10.1
lny9agt75v k63pj
17 Oct 22
Entry into a Material Definitive Agreement
6:00am
8-K
EX-1.1
vno ch8klkoqam3gzy
11 Aug 22
Other Events
5:46pm
424B5
jv2gz6d1hbd8pwmmd4
11 Aug 22
Prospectus supplement for primary offering
5:09pm
424B5
hos0owiqy
9 Aug 22
Prospectus supplement for primary offering
12:00am
S-3
EX-1.2
wxt4dh7mx3 mdbjid
19 Mar 21
Shelf registration
5:23pm
DEF 14A
s9e7m3v0xuaeomk7
19 Mar 21
Definitive proxy
4:02pm
10-K
EX-10.20
o2jy0o8d7n h9
25 Feb 21
Annual report
8:29am
10-K
qlwl5xlu1wv2 9sy
25 Feb 21
Annual report
8:29am